In addition to frameshift mutations caused by dMMR, mutations in the promoter region of the BAX gene have been reported to contribute to reduced BAX expression in chronic lymphocytic leukemia, head and neck squamous cell carcinoma, and breast cancer [36,37,38]. Here, BAX is linked to breast carcinoma.